New Results from the National Health and Wellness Survey Show Patients in Japan with Neuropathic Pain Report Significantly Worse Outcomes Than Those Both without Pain and with Other Forms of Pain
NEW YORK, September 3, 2012—Neuropathic pain is associated with significantly lower levels of health-related quality of life among Japanese patients compared with patients experiencing another type of pain and patients without pain, according to new findings from the National Health and Wellness Survey (NHWS), conducted by Kantar Health and presented today at the ISPOR (International Society for Pharmacoeconomic and Outcomes Research) 5th Asia-Pacific Conference. Neuropathic pain is most commonly caused by diabetes but can also arise from a variety of other chronic conditions (such as herpes zoster) and specific treatments (such as chemotherapy).
Japanese patients with neuropathic pain had significantly lower physical (42.43) and mental (41.60) component summary scores than patients experiencing another form of pain (45.41 and 44.83, respectively) and patients without pain (51.03 and 47.41, respectively). Patients with neuropathic pain also reported significantly more visits to their healthcare provider in the past six months (18.85) compared with patients with non-neuropathic pain (8.21) and patients without pain (4.60).
“Although Japanese patients with neuropathic pain don’t report a higher frequency of pain than patients with other types of pain, they are reporting that the severity of their pain is significantly greater,” says Andy Stankus, Senior Vice President, Asia-Pacific, Kantar Health. “In addition to their lowered quality of life, these patients also have greater activity impairment. Japanese patients with neuropathic pain have significantly worse humanistic and economic outcomes, which suggest that improved management of neuropathic pain may have substantial health outcomes benefits. And, despite this burden, over a third of patients remain untreated, emphasizing the need for improved disease management.”
About the National Health and Wellness Survey (NHWS)
The study’s results were drawn from the 2010 Japan NHWS, a nationally representative, self-administered survey conducted annually via the Internet. Topics covered include the health status, attitudes, behaviors and outcomes among adults 18 or older.
Kantar Health conducts NHWS annually in the US, Europe, Asia and Latin America. The survey is the largest self-reported database in the healthcare industry.
About Kantar Health (www.kantarhealth.com)
Kantar Health is a global, evidence-based decision support partner to the world’s leading pharmaceutical, biotech, device and diagnostic companies. Our 700+ staff act as catalysts, working closely with customers to drive distinctive decision-making that helps them prioritize product development and portfolios, differentiate their brands and ensure product profitability after launch. We are unique in that we bring together clinical, medical and methodological expertise, commercial/marketing know-how and proprietary data. It is this rare combination, together with our unparalleled stakeholder reach, that enables us to mobilize incisive, imaginative and timely ROI-driven solutions, empowering clients to deliver better healthcare options to their customers.
With staff in over 40 countries, we excel at solving technically or logistically challenging projects around the world and across the product lifecycle, combining on-the-ground know-how and global and national proprietary data to quickly identify value drivers. As part of WPP, we can also incorporate highly innovative thinking from outside the industry into our solutions.
For more information on Kantar Health, please contact Paula Paradise, Vice President of Global Marketing, at firstname.lastname@example.org or +1-484-442-1431.